Support teaching, research, and patient care.
Dr. McClung is a fellowship trained, board certified Gynecologic Oncologist with the Stanford Medicine Cancer Center and Clinical Assistant Professor in the Stanford Medicine Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.She graduated from the Icahn School of Medicine at Mount Sinai in New York City and she completed residency in Obstetrics and Gynecology at Stanford Medicine. She then pursued sub-specialty Gynecologic Oncology fellowship at Moffitt Cancer Center and the University of South Florida in Tampa, Florida.Prior to joining Stanford Health Care, Dr. McClung was an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona Banner University Medical Center in Tucson, Arizona.Dr. McClung actively contributes to gynecologic cancer research. She has studied prevention of surgical site infections, gene expression prediction of lymph node metastasis in endometrial cancer, treatment resistance in ovarian cancer, and additional topics. She co-authored articles on her findings for peer-reviewed publications such as the International Journal of Gynecologic Cancer, International Journal of Women’s Health, and Gynecologic Oncology Reports.She authored the chapter on the diagnosis and management of vaginal cancer in the textbook Handbook of Gynecology and has made invited presentations at meetings of the Society of Gynecologic Oncology and other associations. She works to improve patient access to state-of-the-art care as an investigator in cooperative group clinical trials.She has won multiple teaching awards for her work with medical students and residents. She is passionate about increasing awareness of gynecologic cancer in medical trainees.Dr. McClung provides comprehensive care with a personalized approach for patients with gynecologic cancer and pre-cancer including surgery, chemotherapy, cancer risk reduction, and palliative care. She has a strong clinical interest in patient safety and quality of life both during and after cancer treatment.